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ABSTRACT
Trichothecin (T-cin), amphotericin B (AB) and 5- 
fluorocytosine (PC) were compared singly and in combination 
against Cryptococcus neoformans in terms of relative fungi- 
stasis, inhibition of DNA, RNA and protein synthesis and 
chemotherapeutically in experimentally infected mice. The 
minimum inhibitory concentration (MIC) for T-cin, AB and PC 
was found to be 0.5, 0.2 and 5.0 ug/ml respectively. In 
vitro viability studies demonstrated the occurrence of syn­
ergy with the AB-PC combination and additivity with the AB- 
T-cin combination for a three day period. Studies on the 
cellulêu: level were inconclusive in the expleuiation of these 
phenomena. In mice the EDgg (50% effective dose) value for 
AB was found to be 0.38 mg/kg ip and for PC it was 100 mg/kg 
ip for a 30 day time period. T-cin was tested from 0.1 to 
50 mg/kg and no ED^q value could be ascertained, however 1.0 
mg/kg offered the best protection in terms of extending mean 
life expectancy. The most effective drug combination in vivo 
was AB-T-cin where drug synergy was demonstrated. High dose 
T-cin controls survived despite having received a cumulative 
dosage of more than twice the reported LDgg value. Histo- 
pathological evidence supported T-cin toxicity in mice when
toxin was used in high concentrations.
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Trichothecin (T-cin) is produced by the saprophytic 
mold Trichotheciun roseum. It is one of the trichothecene 
class of mycotoxins and as such is a sesquiterpene auid is am 
inhibitor of protein synthesis in eucaryotic ceils (22,23,44). 
Freeman found the LDgg of T-cin in mice to be over 250 mg/kg 
(21). T-cin was also reported by Freeman to be toxic to a 
number of pathogenic fungi in vitro, including Cryptococcus 
neoformans (Torulopsis neoformans) which was inhibited by 
16 yg/ml or less of the compound (21). Preliminary in vitro 
experiments in our laboratory had demonstrated that C. neofor­
mans was sensitive to this drug at less tham 1 ug/ml under more 
defined conditions. The large ratio between the reported LDg^ 
in mice amd the in vitro effectiveness against C. neoformans 
suggested that T-cin might be useful as antibiotic.
Antibiotic properties of the trichothecenes have been 
investigated previously with varying results. Trichodermin, 
a trichothecene similar in activity to T-cin (25) is active
against Candida albicans, and because of its low mammalian 
toxicity has been proposed for treating Candida infections in 
man and for use as an antitumor agent (24). In contrast Free­
man (21) stated that the antifungal activity of T-cin is of 
no practical value in treating infections in animals owing to 
the high toxicity of the antibiotic. Scheiber et al. (26) 
compared T-cin, nystatin, and crotocin, an isomer of T-cin 
in mice experimentally infected via stomach tube with C. albi­
cans. Even though the drugs were found to reduce the number of 
Candida cells in the faeces of mice the excretion of Candida 
cells in the controls was not consistent and the results were 
considered unreliable. Glaz et al. (27) studied the activity 
of antibiotic T which was subsequently referred to as croto­
cin (40) . They found it to be active against C. albicans 
in vitro but not in vivo and concluded that it does not 
promise to be suitable for treatment of systemic mycoses. 
However, Glaz and coworkers had administered only two treat­
ments of crotocin over a 48 hour period. There appeared to 
be sufficient ambiguity in the literature regarding anti­
biosis of T-cin and other trichothecenes to warrant further 
investigation. Ç. neoformans infected mice was selected as 
the test system. For positive controls two drugs presently 
in use for treatment of systemic cryptococcosis were chosen, 
amphotericin B (AB) (14) and 5-fluorocytosine (FC) (14,15).
AB is a polyene antibiotic produced by Streptomyces 
nodosus. It affects membrane properties of fungal and
emiinal cells by binding to sterols in the membrane (10) re­
sulting in leakage of a variety of cellular constituents (11, 
12). The LDgQ of AB in mice is 280 mg/kg ip (41).
The pyrimidine analogue FC has a very low toxicity to 
manmalian cells with marked and rather selective antifungal 
activity against yeast cells in vitro and in vivo (16,17,36). 
The LDgg of FC in mice is 1190 mg/kg ip (17).
There have been recent investigations into the concur­
rent use of AB and FC in vitro and in vivo (3-5, 31,32,45). 
These investigations have pointed to wide disparities in 
C. neoformans strain behavior to AB and FC when used in 
combination. Little information is available comparing in 
vitro with in vivo results of a single strain exposed to this 
drug pair (32). However, under identical circumstances dif­
ferent strains may demonstrate synergism, antagonism or in­
difference to AB and FC when these drugs are used together. 
When used singly AB does not demonstrate this disparity and 
yields more consistent results (30,38,39,42). The activity 
in vitro of FC has been shown to be affected by a number of 
variables (45,46). In vivo FC causes the formation of resis­
tant mutants (8,9,16,18). It is theorized that use of AB and 
FC would eliminate the resistant mutcints resulting from FC 
usage and would reduce the nephrotoxicity caused by AB (6,7) 
by lowering its concentration and still achieve clinically 
significant results.
T-cin has been used also in combination with other 
drugs. In their paper cited above, Scheiber et al. (26) 
had tested the therapeutic efficacy of their antibiotics dur­
ing the concurrent oral administration of oxytetracycline in­
corporated in the food of the mice. To date there have been 
no literature reports regarding the activity of T-cin when 
combined with AB or FC in vivo or in vitro. To study the 
problem of combined drug therapy an experimental animal model 
similar to that of Block and Bennett was chosen (31) .
The desire to compeure T-cin with the control drugs on 
as many bases as feasible lead to the development of two oth­
er phases of the investigation. The first was an initial in 
vitro screening of these drugs in terms of their single and 
combined effects on the viability of Ç. neoformans. as re­
ported previously for AB and FC (13,29,30,45) .
The second was a study of drug interaction on the 
molecular level. Similar investigations have included at 
least one member of the drug pair in high or in veurying con­
centrations (13,28,32) . The use of low êind constant concen­
trations of each drug studied singly and in combination over 
time appeared to us to be a necessary link in the correlation 
of this work with viability counts. This seemed especially 
true if the same concentrations could be used in both cases.
The investigation of the comparative effects of T-cin 
with AB and FC was therefore divided into three primary phases: 
1) in vitro viability studies to determine the minimum inhi­
bitory concentration (MIC) of T-cin, AB and FC against
c. neoformans for a three day period. This phase also in­
cluded combinations of these drugs at one-half MIC (MIC/2) 
amd one-quarter MIC (MIC/4) levels to determine the relative 
fungistatic or fungicidal characteristics of the combination 
pairs, 2) a study at the molecular level of single drugs and 
two-drug combinations in an attempt to corroborate viability 
studies and to investigate the mechanism of action of the 
drug combinations. This work included uptake of ^H-thymidine, 
^H-uridine, and ^H-leucine by C. neoformans at MIC/2 con­
centrations over a four hour time period, 3) in vivo establish­
ment for each drug of cm effective dose at the 50% level (ED^q ) 
against C. neoformans infected mice for a 30 day treatment 
period. This phase included an investigation into combined 
drug therapy in which the drugs were combined at ED^g or one- 




Medium. A modified Wickerhcun's medium designated M9A 
was employed in all experiments to grow the cells. The medium 
consisted of Wickerham's concentration of trace elements and 
salts, 1% (w/v) glucose, 0.5% (w/v) vitamin free casamino acids 
(Difco) and thiamin at 0.2 yg/ml. Ammonium sulfate was omitted.
Cells. Cryptococcus neoformans strain No. 184 was 
used in all in vitro and in vivo studies. The strain was 
originally isolated from a human patient and was provided by 
Dr. L. Friedmëui, Charity Hospital, New Orleans, Louisiana.
Growth. For minimum inhibitory concentration (MIC) 
studies cells were inoculated by the loop method and grown 
for 24 hours in M9A on a rotating shaker at 37 C, diluted 
with fresh medium to 10^ cells/ml and allowed to grow over­
night until ca. 10® cells/ml was obtained. They were then 
tremsferred in 50 ml aliquots to sterile flasks to which 
drugs were added singly at varying concentrations. After an 
initial screening, two-fold serial dilutions of each drug 
were prepared to determine the MIC. In subsequent experi­
ments drugs were added singly or in combination at fraction­
al MIC levels. Ten ml from each flask was treinsferred to
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each of four 125 X 15 nnn test tubes and placed on a New Bruns­
wick tube platform (New Brunswick, N.J.) on a 15 degree angle, 
and shaken for three days at 37 C. Duplicate tubes were re­
moved after 24 amd 72 hours. Cell counts were made after 
dilutions by spread plating in triplicate on Sabouraud Dex­
trose Agar (SDA) to determine the number of colony forming 
units (CFU). All experiments were duplicated and the re­
sults averaged.
Isotope studies. Cells were grown as above. A 500 ml 
Erlenmeyer flask containing 250 ml of M9A was used for each 
cell workup. When ca. 10® cells/ml was obtained (hemacyto­
meter count) isotope was added to the stock flask and 30 ml 
was dispensed into each of seven 125 ml Erlenmeyer flasks. 
These were replaced on the sheJcer for 4 hours for adaptation. 
Drugs were then added singly or in combination at one-half 
MIC concentrations (MIC/2) to appropriate flasks by addition 
of 100 yl of each drug. The flasks were placed on the shaker 
for 5 minutes and the T^ measurements were then taken. Acid 
precipitable counts were determined by withdrawing one ml 
frcxn each flask and adding to tubes containing 1 ml ice cold 
10% trichloroacetic acid (TCA). Samples were filtered through 
millipore filters (0.45 u) and tubes were washed three times 
with 10 ml each of 5% ice cold TCA. Duplicate data points 
were taken hourly at T^ through T^ hours. DNA, RNA and pro­
tein experiments were duplicated and the results averaged.
In vivo studies. Cells were grown for 24 hours in M9A, 
washed 3X in physiological saline (PS) and diluted to 10®
8
cells ml in PS.
In all experiments initial viable counts were also 
determined to confirm hemacytometer counts.
Isotopes. Thymidine-Methyl-^H (specific activity 
43.1 Ci/mmole) and Uridine-5,6-^H (specific activity 45 Ci/ 
mmole) were used at 0.5 uCi/ml final concentration and L-leu- 
cine-4,5-^H (specific activity 50 Ci/mmole) was used at 1.5 
yCi/ml final concentration. Isotope fluor was dioxane base 
Aquafluor.
Isotope and fluor were purchased from New England 
Nuclear (Chicago, 111.).
Drugs. T-cin was obtained as previously described (33). 
T-cin stock solutions and dilutions were prepared in distilled 
water (DHjO). For animal inoculations T-cin was dissolved in 
light mineral oil (Markol 52, Exxon Petroleum Co.).
Crystalline 5-fluorocytosine was purchased from Hoff- 
man-La Roach (Nutley, N.J.) and prepared in DHgO for in vi­
tro studies and in PS for in vivo experiments.
Amphotericin B (Fungizone, Squibb) was reconstituted 
and diluted with 5% dextrose in water.
All drug stock solutions were sterilized by filtration. 
They were kept in dark containers and refrigerated at 4 C 
when not in use.
Assessment of drug activity. The minimum inhibitory 
concentration (MIC) was defined as the lowest concentration 
of each compound which completely inhibited multiplication of 
C. neoformans strain 184 over the three day experimental time
period. The exception to this was FC for which a two day 
period was chosen since overgrowth could not be prevented with 
this strain after two days even with much higher concentrations 
of the drug.
An additive effect will be defined as the same effect 
achieved by the sum of two drugs used in combination at reduced 
concentration as that effect achieved by the single most effec­
tive drug when used alone. Under these circumstances the 
single drug is used at a dose equivalent to that of the mix­
ture (1,2).
In the viability studies antifungal synergy was defined 
as a decrease in 10-fold or more in colony counts after three 
days when drugs were used in combination at reduced concentra­
tion as compared to the counts when a single drug was used 
alone (13).
Mice. Six to eight week old BALB/cj inbred white mice 
were used. Mouse weights varied between 25-30 grams per 
experiment. Drug dosages were adjusted accordingly. All 
groups of mice were weighed at the time of treatment. On 
day 1 mice were inoculated intravenously via a lateral tail 
vein with 0.1 ml of a 10® cells/ml suspension of C. neoformans 
strain 184. Drug treatment began on day 4 and 14 alternate 
day dosages were administered for a 30 day experimental time 
period. All drugs were administered via the intraperitoneal 
route. Injection amounts varied between 0.1 to 0.4 ml de­
pending upon the drug and its concentration. Mice were 
housed in groups of five. Each dosage group contained 10
10
mice, 5 males and 5 females. They were provided water and 
food (Purina Lab Chow) ad libitum. Mice were maintained on 
a 12 hour day-night cycle.
Dead mice in all euiimal experiments and surviving mice 
of the combined drug experiment were autopsied. The spleen 
and brain were ground with a tissue homogenizer and plated on 
SDA containing 100 units of penicillin and 100 \xg strepto­
mycin/ml. Growth of yeast-like colonies at 37 C and examina­
tion of random colonies by India ink wet mount constituted
positive identification criteria for C. neoformans. Plates
containing less than four colonies were classified as nega­
tive. All plates classified as positive produced confluent 
growth.
Experimental. Three mouse experiments were conducted. 
The first consisted of 1.0, 2.5, 5.0, 7.5 and 10 mg/kg lev­
els of T-cin only. The second experiment consisted of mice 
receiving treatment by AB, FC or T-cin. AB dosages tested
included 0.1, .25, .50, .75, 1.0 and 1.5 mg/kg. FC dosages
tested included 10, 25, 50, 100 and 150 mg/kg- Due to the 
large quantities of T-cin necessary for the study auid the de­
sire to maintain uniform numbers of mice for each dosage regi­
men the second experimental T-cin group contained only five 
mice per dosage (males). These included the 0.1, 1.0, 10, 25 
and 50 mg/kg levels. All other animal groups contained ten 
mice per dosage regimen. Control groups consisted of unin­
fected, infected, solvent and high dose controls. The latter 
group contained five mice each in the case of T-cin. At the
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conclusion of the experiment the high dose T-cin controls 
were inoculated with C. neoformans. In addition ten other 
mice of the same age were inoculated to serve as positive 
controls.
Synergy studies. The third mouse experiment was an 
investigation of drug combinations in infected mice. Combina­
tions were studied at the ED^g and EDgg/2 levels, which were 
ascertained as a result of experiment two. Controls consisted 
of T-cin at 1.0 mg/kg and 0.5 mg/kg, FC and AB at ED^q levels, 
uninfected and infected mice.
Histopathological . In addition to the three mouse ex­
periments two mice were injected ip with T-cin at a concen­
tration of ca. 250 mg/kg and one was injected ip with T-cin at 
a concentration of 50 mg/kg. The toxin was dissolved in 
warmed corn oil. The mice used in this work were six week 
old CBA Bar Harbor white mice, with an average weight of 17- 
18 grams. The mice were sacrificed after 24 hours, autopsied, 
and the thymus, bone marrow, liver, and kidney were examined 
histopathologically by Dr. James Price at the University of 
Oklahoma Health Sciences Center.
CHAPTER III
RESULTS
In vitro. Table I lists the MICs and their respective 
cell counts in the viability studies. The MIC of T-cin was 
only about twice the MIC of AB. The MIC of FC was determined 
to be 5 yg/ml for a two day period or > 150 yg/ml for three 
days since all concentrations tested up to 150 yg/ml were un­
able to maintain viable counts at or below 10® CFU/ml for 
the longer time period. The most effective MIC/2 combination 
(each drug at one-half MIC) after three days (Table II) was 
AB-FC which demonstrated synergy by the criterion of Medoff 
et al. (13). The AB-T-cin MIC/2 combination approximated an 
additive effect based upon the comparative value of its CFU 
with that of the MIC with the lowest counts after three days 
(AB). An additive effect would be interpreted for the FC- 
T-cin MIC/2 combination for the same reason. However due to 
the apparent inactivity of FC after two days the combination 
might be expected to equal T-cin/2 controls; CFU for the 
combination is seven fold below this value. Other combinations 




Uptake of labelled substrates. All combinations in 
thymidine uptake (Figure 1) fall below single drug points 
for the greater part of the four hour time period but dif­
ferences are often insignificant. Significance was deter­
mined by comparison of standard errors based upon differ­
ences between means. (Time periods at which differences are 
significant are marked with an arrow.) Only the synthesis of 
RNA in general appears to be significantly affected by in­
dividual drugs and their ccmibinations (Figure 2) as evidenced 
by negative slopes. The AB-T-cin combination appears to
exert its major effect here since all points are significantly
\
below points belonging to single drugs. The other two combina­
tions appear to exert greater than additive effects at T^ 
and < but the meaning of the occasional synergy in terms 
of long term cellular inhibition is not clear. Protein 
synthesis (Figure 3) appears to be the least affected of the 
three cellular processes studied. For the most part combina­
tions had little or no apparent effect on the uptake of leu­
cine compared with the single drugs except for the AB-T-cin 
and AB-FC combinations for which one point of significant dif- 
erence was noted at T^ auid T^ respectively. A direct compari­
son of drug combinations "or the three cellular processes 
studied is presented in Figure 4. While FC-T-cin shows rela­
tive inactivity compared with the other combinations in all 
uptake measurements, the AB-T-cin group shows the lowest ini­
tial counts in protein synthesis and after four hours in RNA
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synthesis. Finally, the AB-FC pair shows a significant re­
duction in DNA synthesis after three hours compared with the 
other two combinations.
In vivo single drug experiments. The curative effect 
of various concentrations of AB and FC on mice infected with 
C. neoformans is graphically represented in Figure 5 (A and B). 
The EDgQ of AB was determined as . 38 mg/kg on the basis of 
percent survivors. The ED^g of FC was 100 mg/kg. No EDgg 
for T-cin could be obtained at 30 days since all concentra­
tions tested fluctuated around control values (Figure 6C).
All five of the 50 mg/kg high dose T-cin controls survived 
despite having received a total of 700 mg/kg, more than twice 
the estimated LDgg value (25) . When challenged on day 33 with 
C. neoformans all five mice died within the next 30 days 
(Figure 6D) while only 7 out of 10 controls infected at the 
same time succumbed- A comparison of T-cin with AB amd FC 
for the single drug experiment is presented in Table III. It 
should be noted that the concentration of 1.0 mg/kg T-cin 
offered the best protection to mice of all T-cin concentra­
tions tested in terms of extending mean life expectancy (MLE).
Histopathological ■ The mice injected with 250 mg/kg 
T-cin exhibited marked cortical depletion of the thymus and 
evidence of hemorrhage in the kidney, liver and lung and 
definitely decreased myeloid elements in the marrow of one 
with a hyperplastic myeloid marrow in the other. The mouse 
injected with 50 mg/kg T-cin demonstrated liver parenchymal 
cells with areas of fatty degeneration or intracellular fatty
15
infiltration. The kidney showed moderate congestion in the 
area of medullary rays. The c o m  oil injected control pos­
sessed tissues described as unremarkable.
Combined drug experiment. The various drug combina­
tions used in the combined drug experiment are compared in 
Figure 7. Results are expressed as percent survivors at 30 
days. It can be seen that the AB-FC ED^q group (each drug at 
EDgQ level) allowed greater percent survivors than either 
control but since each drug in the combination was at ED^g 
concentration twice the drug dosage was given. At one-half 
the EDgg concentration of each drug (EDgg/2) the same results 
were achieved as the AB ED^q. This is considered an additive 
effect. The value of 1.0 mg/kg T-cin was chosen for use in 
the combined drug experiment for the purpose of conservation 
of toxin and since this concentration had offered the great­
est protection to the mice in terms of extending mean life 
expectancy (MLE). Both AB-T-cin combinations demonstrated 
synergy since a greater percentage of survivors over controls 
was noted even though T-cin is inactive by itself. The FC-T- 
cin pair shows effects approximating those of FC alone, 
suggesting that T-cin does not act in combination with this drug.
In Figure 8 the MLE of the various groups is depicted.
The relative positions of the drug pairs are similar to those 
described for Figure 7. In general, drug combinations extend­
ed the MLE over single drug controls- The MLE of the un­
treated controls is 21.0 days in this experiment in contrast 
to 15.7 days in the single drug experiments.
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In Figure 9 the cumulative total weight gain per 
mouse is shown over the 30 day experimental time period.
It can be seen that the most effective combinations were the 
high dose groups in which little weight loss was observed. 
Compared with other low dose combinations the AB-T-cin ED^q/2 
pair was the most effective.
Results of the combined drug experiment are summarized 
in Table IV. Positive organ cultures are shown as a fraction 
of total mice autopsied. Spleen cultures considered negative 
were observed for all high dose drug combinations and brain 
cultures considered negative were observed only for the FC 
EDjq and AB-FC EDgg/2 groups. All of the high dose T-cin 
control mice (uninfected) suffered severe weight loss of up to 
11 grams per mouse and their coats were unkempt and ruffled 
after having received a total of 250-350 mg/kg T-cin. There­
after recovery amd weight gain were rapid. At the conclusion 
of the experiment the mice weighed only 4.6 grams less than 
their initial weight at the start of the experiment.
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Table I. Minimum inhibitory concentrations (MIC) for T-cin 
and AB were based on a three day time period. The 
MIC for FC was determined after two days since all 
concentrations tested were ineffective after this 
time. Results in viable counts are expressed as 
colony forming units (CPU) per ml. Combined drug 





ug/ml Day 1 Day 2 Day 3
T-cin 0.5 9.8 X 10® b 9.0 X 10®
AB 0.2 5.5 X 10® b 5.8 X 10®
PC 5.0 4.7 X 10® 5.7 X 10® 4.4 X lo’




Table II. Results of in vitro drug combination studies. The 
most effective combination was AB-FC one-half MIC, 
i.e. each drug at MIC/2 concentration, in which 
CPU were reduced more than ten fold below the MIC 
for the most effective single drug. Single drugs 
and drug combinations other than MIC/2 pairs are 
shown for comparative purposes only.
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Tq = 10® CFü/ml
ug/ml Day CFüVml1 Day 3
Untreated controls 2.6 X lo’ 9.0 X lo’
Single drugs:
T-cin/2 .25 5.1 X 10® 6.7 X 10®
AB/2 .1 1.9 X 10® 9.2 X 10^
FC/2 2.5 8.9 X 10® 3.5 X lo’
T-cin/4 .125 1.6 X 107 5.6 X lo"
AB/4 .05 7.0 X 10® 8.0 X lo’
FC/4 1.25 1.2 X 10® 5.6 X 10-7
Combinations:
AB/2 - FC/2 5.8 X 10® 6.3 X 10®
AB/2 - T-cin/2 6.3 X 10^ 4.3 X 10®
FC/2 - T-cin/2 9.4 X 10® 9.5 X 10®
PC/4 - T-cin/4 8.8 X 10® 9.9 X 10®
AB/4 - FC/4 2.3 X 10® 4.0 X 10®
AB/4 - T-cin/4 1.1 X 10® 1.2 X lo’
AB/2 - FC/4 8.7 X 10® 6.3 X 10^
AB/4 - T-cin/2 2.5 X 10® • 7.0 X 10®
FC/2 - T-cin/4 8.8 X 10® 1.0 X 10®
FC/4 - T-cin/2 9.4 X 10® 1.0 X 10®
AB/4 - FC/2 1.0 X 10® 1.5 X 10®
AB/2 - T-cin/4 1.3 X 10® 6.7 X 10®
^Colony forming units
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Figure 1. Inhibition of DNA synthesis by single drugs each 
at one-half MIC (MIC/2) level and by two drug 
combinations. Points where differences are sig­
nificant are marked by an arrow. Although drug 
combinations were usually below single drug counts, 
differences were often insignificant and continuous 
inhibition by the combinations was not observed.





























Figure 2. Inhibition of RNA synthesis by single drugs each 
at one-half MIC (MIC/2) level and by two drug 
combinations. Points where differences are sig­
nificant are denoted by an arrow. Marked inhib­
ition by all drugs and combinations is observed. 
The most effective drug pair appears to be AB-T- 
cin where percentage inhibition is well below 
single drug effects for the entire four hour 
period.
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Figure 3. Inhibition of protein synthesis by single drugs
each at one-half MIC (MIC/2) level and by two drug 
combinations. Points where differences are sig­
nificant are marked by an arrow. Drug combina­



























Figure 4. A comparison of the three two-drug combinations is 
shown for each of the cellular processes studied. 
Points wheis differences are significant are de­
noted by an arrow. O = AB-FC, X = AB-T-cin and 
O = FC-T-cin. The AB-T-cin combination was the 
most effective of the three in terms of inhibition 
of RNA and protein synthesis. The AB-FC combina­
tion was the most effective in terms of DNA in­
hibition. The FC-T-cin pair was relatively in­


























Figure 5. Mortality curves for amphotericin B (graph A) and 5-fluorocytosine (graph B)
compared with untreated controls. The EDg^ for amphotericin B was established 
at .38 mg/kg and 100 mg/kg for 5 fluorocytosine. w
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Figure 6. Graph Ci Mortality curves for trichothecin (T-cin) treated mice. All groups
contained five animals except controls which had ten mice. The longest sur- w
vival time of the dosages tested was offered by the 1.0 mg/kg regimen. No 
EDgg could be obtained since 80-100% death occurred in all cases. Graph Ds 
Mortality curves for infected high dose T-cin treated mice compared with un­
treated controls. The five high dose T-cin controls from experiment 2 
(50 rag/kg) were infected with C. neoformans on day 33. In contrast to T-cin 
treated mice in experiments 1 and 2 these mice demonstrated a higher mortali­
ty rate than controls. Mean life expectancy (MLE) and its standard error (Sg) 
are shown. MLE was not significantly affected.
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Table III. Summary of single drug animal experiments 1 and 2.
Experiment 1 consisted of C. neoformans infected 
mice treated with T-cin only. In experiment 2 
infected mice were treated with T-cin, AB or FC.
Drug (mg/kg) No. of mice % survivors mean life standard
tested at 30 days expectancy (days) error of mean
Experiment 1
Controls 20 5 17.0 0.8T-cin 1.0 10 10 18.9 1.62.5 10 0 14.7 1.4
5.0 10 10 16.9 1.87.5 10 20 17.5 2.310.0 10 0 17.7 1.8
Experiment 2
Controls 10 0 15.7 1.1T-cin .1 5 0 17.8 1.6
1.0 5 0 23.4 1.910.0 5 20 19.3 2.3
25.0 5 0 21.2 2.050.0 5 20 14.8 1.5
AB® .10 10 20 20.3 1.1.25 10 40 22.7 1.6
.50 10 60 24.8 1.1
.75 10 90 29.8 0.2
1.0 10 90 29.8 0.2
1.5 10 100 30.0 0
FC^ 10 10 10 19.2 1.2
50 10 40 22.8 1.6
100 10 50 26.4 1.5
150 10 60 22.5 1.5
*EDgQ = .38 mg/kg
^EDgQ = 100 mg/kg
w
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Figure 7. Results of the combined drug experiment expressed 
in terms of percent survivors at 30 days. Drug 
combinations consist of each drug of the pair at 
the EDgQ or EDjq/2 (one-half EDgg) concentration; 
T-cin in these respective combinations is at 1.0 
and 0.5 mg/kg. The 1.0 mg/kg T-cin controls are 
shown. Both AB-FC combinations showed additive 
effects vdiile synergy was demonstrated with the 
AB-T-cin combinations since T-cin is inactive when 
used alone.













Figure 8. Results of the combined drug experiment expressed 
in terms of mean life expectancy (MLE). Drug 
combinations consist of each drug at ED^Q or 
EDgg/2 (one-half EDgg) concentration; T-cin in 
these respective combinations is at 1.0 and 0.5 
mg/kg. The 1.0 mg/kg T-cin control group is shown. 
The relative positions of all combinations approxi­
mates that of Figure 7. The FC-T-cin EDjq/2 group 
showed a significantly lower MLE than the controls.
MEAN LIFE EXPECTANCY (DAYS)
OI
o







Figure 9. Results of the combined drug experiment expressed 
in terms of cumulative total weight gain per 
mouse after 30 days. Drug combinations consist of 
each drug at ED^q and ED^q/2 (one-half ED^q) con­
centrations; T-cin in these respective combina­
tions is at 1.0 and 0.5 mg/kg. The 1.0 mg/kg 
T-cin control group is shown. All high dose drug 
combinations were effective in preventing signifi­
cant weight loss and the FC-T-cin low dose group 
was the least effective. Low dose combinations 
are shown for comparative purposes only.
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TablG IV. Summary of combined drug experiment (experiment 3). All experimental groups 
contained 10 mice. Drug pairs at EDgg level contained AB or FC at the EDgg 
dosage with T-cin at 1.0 mg/kg. Drug pairs at EDjq/2 level (each drug at 









Fraction of positive 
cultures 
Spleen Brain
Total wt. gain 
per mouse (gms) 
cumulative
Experiment 3 
Controls 10 21.0 1.5 1/1 1/1 -7.6
AB EDgo 60 27.3 1.3 6/6 6/6 -3.5
PC ED50 40 25.3 2.3 4/4 3/4 -3.7
T-cin 1.0 mg/kg 10 22.1 1.6 1/1 1/1 -6.8
T-cin 0.5 mg/kg 0 18.9 1.9 0 0 -7.3
AB-FC EDgQ 90 30.0 0 7/9 7/9 +1.2
AB-FC ED5Q/2 60 25.5 0.5 6/6 6/6 —2.0
AB-T-cin EDgQ* 90 29.3 0.7 7/9 9/9 0
AB-T-cin EDgg/zb 50 24.4 2.7 5/5 5/5 -1.1
FC-T-cin EDgg* 50 24.4 0.9 3/5 5/5 -1.5
FC-T-cin EDgg/2*’ 30 16.4 1.5 3/3 3/3 -5.2
T-cin high dose 100 30.0 0 5/5 5/5 -4,6
*T-cin at 1.0 mg/kg 
^T-cin at 0.5 mg/kg




The MIC of AB against C. neoformans strain 184 was 
established at 0.2 ug/ml. This is supported by Shadomy et al. 
(38) who report 80% of 77 strains of this yeast to have 
an MIC of 0.2 yg/ml or less for AB. Nearly 100% of the PC 
pretreatment isolates of C. neoformans studied by Shadomy (46) 
and all 55 of those of Block et al. (35) were shown to be 
sensitive to 10 wg/ml or less of the drug for a 48 hour period, 
in agreement with our results of 5 yg/ml. After this period 
of time nine percent of the strains of Block et al. (35) 
developed drug resistance. This might help explain the high 
concentrations of PC necessary to suppress growth for longer 
periods of time in these experiments. The MIC of T-cin 
against C. neoformans has not been established, although 
Preeman (21) reports that this yeast is sensitive to 16 yg/ml 
or less of T-cin. I am reporting the MIC of T-cin to be 
0.5 yg/ml for the strain of Ç. neoformans used in this study.
An examination of cell counts for one day only shows 
that of the MIC/2 combinations, AB-PC reduced CPU ca. 11-fold
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below the AB-T-cin pair which in turn gave counts ca. 15-fold 
below the FC-T-cin pair. The difference between the first amd 
last of these three pairs is over 160-fold. No clearcut quan­
titative differences could be observed in the radioisotope 
experiments even though the same drug concentrations amd med­
ium were employed. Therefore these experiments could not 
clearly define the mechanisms by which this synergism was 
occurring. The statement by Medoff et al. seems particularly 
appropos. "The effects of the drugs on shortterm growth or 
FNA synthesis are much less marked than the reduction in col­
ony counts at 7 days but they are consistent with a cumulative 
inhibition that finally kills the cells" (13).
Fluctuations between single drugs amd their combina­
tions is often a time dependent occurrence (1) and in our 
case is exemplified by the changing ratios of the combina­
tions to one another or to their controls in viability counts 
at one and three days. Assuming this fluctuation may also 
occur on the molecular level different combinations appear 
effective at different times. Of the three combinations 
tested AB-FC significantly demonstrates the lowest relative 
counts in DNA synthesis at three hours and the AB-T-cin pair 
the lowest relative counts in protein and RNA synthesis at 
one and four hours respectively.
In their study regarding AB and FC synergy on the 
cellular level Medoff et al. (13) were able to show that less 
than one-half MIC of AB was capable of potentiating the ef­
fects of FC and rifampicin in C. albicans. On the other hcind.
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these concentrations of AB alone resulted in no marked in­
hibition in RNA synthesis. Kwan et al. (28) reported simi­
lar results in Saccharomyces cerevisiae. Marked inhibition 
of RNA synthesis caused by T-cin is difficult to justify and 
is in conflict with published reports on other trichothecenes 
(43,48,49). This difference is as yet unexplained. The 
effects of FC of RNA synthesis in yeast have been described 
(19,20). It is also difficult to explain the apparent cyto- 
cidal effect of the AB-FC and AB-T-cin combinations in via­
bility studies (Table II) on the basis of four hour isotope 
experiments. Viability platings made at the same time that 
isotope data points are taken might reveal a closer correla­
tion between the two.
In the study by Block and Bennett (31) in which AB and 
FC were used to treat mice experimentally infected with 
C. neoformans, they ascertained the ED^g of FC to be 50 mg/kg 
when ip injections were given daily. In this experiment 100 
®9/kg was administered on an alternate day basis, for equiva­
lent dosage. These authors have also reported a ED^g of .86 
mg/kg for AB when injected intravenously. In this work the 
value was .38 mg/kg ip. The difference could be due to the 
strain of mouse used and route of inoculation as well as to 
other variables (37).
The AB-FC EDgQ group permitted 90% survival in mice, 
however total drug concentrations equalled twice as much as 
individual BD^q controls. Since doubling the ED^q concen­
tration of AB also gives improved survival rate and MLE, it
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seems likely that the same holds true for FC.
Although the AB-FC MIC/2 group was the most effec­
tive in vitro, the AB-FC ED^q/2 group demonstrated only ad­
ditive effects in vivo, similar to the results obtained by 
Block and Bennett (31). These authors did not state whether 
their strain of C. neoformans had demonstrated synergism with 
these two drugs in vitro.
At the concentrations tested the in vitro experiments 
suggest only an additive effect when AB and T-cin are used in 
combination. Yet synergy appears to be occurring with both 
AB-T-cin EDgg and EDgg/2 combinations in vivo. Increased ef­
fect due to the addition of an inactive agent is clearly syn­
ergistic (47). One possible explanation for this difference 
between in vitro and in vivo results is that T-cin may be 
biologically modified in the mouse into a compound that is 
also active against C. neoformans. This compound might be 
less permeable to the yeast cell than is T-cin, unless it is 
assisted by AB, but not FC. This may explain why an effect 
approximating that of FC when used alone is achieved in the 
FC-T-cin combinations in vivo. The data presented in Figure 
6C and the fact that high dose T-cin controls survive despite 
the large cumulative amount of toxin received suggests that 
T-cin is inactivated in the mouse. Supportive evidence for 
the degradation of T-cin and crotocin is offered by Horvath 
and Varga (50) who showed that these conç>ounds were able to 
induce the synthesis of enzymes in Pénicillium which lead to
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their inactivation by ester cleavage. In addition, Glaz et 
al. <27) found that intravenous injection of crotocin at two 
to four mg per mouse resulted in a serum level ten times lower 
than expected. These authors point out that although the anti- 
fungal effect of crotocin and T-cin is inactivated in human or 
mouse serum the alcohol cosponent of crotocin is not inacti­
vated and that it is easily soluble in water. The close 
structure-activity relationship between crotocin and T-cin 
suggests that similar physical and biological properties can 
be expected of T-cin. Structure-activity relationships amd 
the relative solubility of trichothecene parent alcohols is 
reviewed by Bamburg and Strong (25)and Wei and McLaughlin (44).
High dose T-cin control mice demonstrated clinical 
signs only when mice were given near lethal doses, results 
similar to those of Kosuri en al. (34) who studied T-2 toxin 
in rats. There was a gradual loss of body weight in our mice 
not seen in solvent treated controls which reached a minimum 
after mice had received 500 mg/kg T-cin. Thereafter recovery 
was rapid. The gradual loss of weight suggests a lack of 
tolerance to the concentrations of drug used. The survival 
emd apparent recovery of these mice by the conclusion of the 
experimental period did not rule out possible adverse ef­
fects of T-cin on the mammalian system. Subsequent infection 
of this group with neoformans resulted in 100% mortality 
conpared with 70% mortality in the control group. The sur­
vival of 30% of the controls may be due to the physical and
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immunological maturity of these mice which were now 10 to 
12 weeks old as con^ared to the six to eight week old mouse, 
upon which initial dosages were based. A greater resistance 
to the pathogen would be expected in the mature mouse. 
Therefore the enheuiced death rate observed in T-cin treated 
mice suggests toxic effects of high concentrations of T-cin 
in these animals. This is supported by our histopathological 
findings on mice injected with a single high dosage of T-cin.
In conclusion, although T-cin is active in vitro 
against C. neoformans it may be rapidly degraded in the mouse 
and is ineffective when used alone in the treatment of sys­
temic cryptococcosis. In vitro the AB-T-cin combination 
demonstrated an additive effect while marked synergism was 
noted for this drug pair in vivo. A more comprehensive study 
of this drug combination using low concentrations of T-cin 
and AB coupled with histopathological studies might reveal 
more concerning the relative toxicity of this drug pair com­
pared with AB alone emd hence better describe the chemo­
therapeutic efficacy of T-cin.
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APPENDIX I
FILTRATE AND MYCELIAL QUANTITATION OF TRICHOTHECIN BY 
MULTIPLE ASSAY TECHNIQUES
In a previous paper Sorenson et al. (1) described the 
development of three assay techniques for the quantitation of 
trichothecin, a mycotoxin produced by the saprophytic mold, 
Trichothecium roseum. These techniques included a colorimetric 
assay (Poltorak), a bioassay using Candida albicans as the 
test organism, and quantitative thin layer chromatography 
(TLC). These methods were shown to be in close agreement with 
one another when applied toward the quantitation of T-cin in
filtrate fractions under the growth conditions described. In
subsequent work with the bioassay and Poltorak method, dis­
crepancies were occasionally noted. This appeared to be es­
pecially true in attempts to quantitate the amount of toxin 
present in the mycelium. In addition, the relative values of 
these two assay methods occasionally varied with different 
strains (1).
Both the bioassay and Poltorcüc methodsof assay are 
semiquantitative. Since many carbon tetrachloride (CCl^) 
soluble compounds are capable of inhibiting C. albicans in 
addition to T-cin their presence could cause an increase in 
zone size in the bioassay. Although intended as a specific 
assay for T-cin, the Poltorak method is also subject to
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variation in that the final blue color can be masked by the 
presence of reactive metabolic biproducts. These meteüxjlites 
may react in the sulfuric acid step of the reaction but not 
the methanol step. The darkened solution therefore tends to 
obscure the colorimetric reaction.
It appeared that a more thorough comparative study of 
these assay techniques might provide evidence for the presence 
of other toxins as well as information regarding the metabo­
lism of T-cin by T. roseum. In order to determine conditions 
of maximum toxin production as measured by two or more of the 
techniques described above, an active toxigenic strain of 
T. roseum (NRRL 1665) was grown under varying culture con­
ditions using either glucose or sucrose as a carbon source.
MATERIALS AND METHODS
All growth experiments were carried out using 2.8 
liter Femback flasks containing 750 ml of the medium of 
Freeman and Morrison (2). Each flask was inoculated with a 
10-day old slant of T. roseum grown on malt extract agar.
All flasks were incubated in the dark.
Two experiments were conducted. In the first experi­
ment glucose and sucrose were used separately as carbon 
sources at varying concentrations eind at ambient room temper­
ature for a three-week time period. Each carbon source was 
tested in duplicate flasks at concentrations of 50, 60, 70, 
80, and 90 grams/liter. After three weeks the flasks were 
autoclaved. The culture was then filtered through a double 
thickness of cheese cloth, extracted, auid quantitated by bio­
assay and Poltorak method, as previously described (1). The 
remaining mycelium was washed with three 100 ml portions of 
distilled water, removed from the flask, allowed to drain 
through cheese cloth for a few minutes and then dried out for 
three hours at 110 C. Each mycelial sample was then powdered 
in a mortar and weighed. This experiment was conducted twice 
and the results averaged.
In the second experiment sucrose was used at a concen­
tration of 80 greuns/liter since experiment one had shown
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tnavimiim T-cin production at this level. Both filtrate and 
mycelium were assayed at two, three and four weeks cuid at 
20 C, ambient room temperature and 28 C. The methods of 
quaintitation were bioassay, Poltorak method eind TLC. The 
latter was applied to the filtrate but not to the mycelial 
fraction because of the viscous nature of the mycelial ex­
tract and because of the presence of a high concentration of 
metabolic biproducts which tended to obscure tlie trichothecin 
spot. The TLC solvent system used was benzene-ethyl acetate 
(95:5) double development (1).
The filtrate and mycelial fractions were prepared as 
in the first experiment. Each mycelial sample was then ex­
tracted in a Soxhlet apparatus for 24 hours with CCl^, evapor­
ated in vacuo and reconstituted to 10 ml in CCl^ for quamtita- 
tion.
RESULTS
Figure 1 shows the toxin production of T. roseum when 
glucose auid sucrose were used as carbon sources at varying 
concentrations. The dry weight of mycelium is also shown. 
Results are expressed as yg T-cin/ml filtrate. With strain 
1665, glucose proved to be a better carbon source for toxin 
production at all sugar concentrations tested. The dry 
weight of the mycelium was also higher with glucose as a 
carbon source with maximum weight yield at 80 g/1, which 
correlated with peak toxin yield. T-cin was assayed at ca.
300 yg/ml filtrate with the use of glucose in contrast to 
sucrose which allowed the production of ca. 150 yg T-cin/ml 
filtrate. In all analyses the bioassay gave higher values than 
the colorimetric assay. There appeared to be less discrepancy 
between the two methods of analysis when sucrose was the car­
bon source.
Figure 2 shows the results of filtrate and mycelial 
analysis of sucrose cultures over time. At all temperatures 
toxin production was maximal in the filtrate after four weeks 
as measured by either assay method. In analyses of filtrates, 
bioassay values were consistently higher than Poltorak values 
at all temperatures studied. On the other hand, Poltorak
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values tended to be higher in mycelial êmalyses. This dif­
ference appears to be consistent with T. roseum strain 1665.
In the mycelium the greatest toxin yields were at room temper­
ature (ca. 20 mg T-cin/g mycelium). Both assay methods were 
in agreement after four weeks at this temperature. In the 
mycelium the greatest discrepêuicy between the two assay 
methods was at 28 C.
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Figure 1. Trichothecin production by T. roseum using varying 
concentrations of glucose or sucrose as the carbon 
source. Filtrate analysis was performed by bio­
assay and Poltorcüc method. Mycelium extracted 
fiom glucose and sucrose cultures is shown as a 
solid line and broken line, respectively. Experi­
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Figure 2. Filtrate and mycelial analysis of trichothecin
over time using sucrose as the carbon source. The 
filtrate was quantitated by bioassay, Poltorak 
method and TLC. The mycelium was quantitated by 
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DISCUSSION
The high bioassay values in the filtrates suggest the 
possible presence of an additional biologically active com­
pound. In addition to T-cin, crotocin and trichothecolone 
have also been recovered from culture filtrates of T. roseum 
(3). Therefore the lower Poltorak measurements probably more 
closely reflect the true T-cin concentration. In filtrate 
analyses assay methods were in closer agreement earlier in 
the growth period. In mycelial analysis, higher relative 
Poltorak values suggests that contaminating metabolic by­
products are present and therefore bioassay values are prob­
ably closer to the true T-cin concentration. At 20 C appear­
ance of T-cin in the mycelium increases almost linearly with 
time as does appearance of T-cin in the filtrate. At room 
temperature mycelial release of toxin occurs at an increasing 
rate, peaking at three weeks. Analysis at 28 C suggests that 
very little T-cin is retained in the mycelium (although other 
biologically active substances may be) emd release of toxin(s) 
into the supernatant occurs rapidly. If additional biological­
ly active compounds are present, they would probably be pro­
duced at varying times and at different rates. Thus dif­




In conclusion, the use of either the bioassay or the 
Poltorak colorimetric method for the quantitation of T-cin 
under the conditions described can yield anomalous results. 
These two assay techniques should ideally be used in con­
junction with one another, preferably in conjunction with TLC. 
However, for initial screening the Poltorak method is recom­
mended for supematcuit analysis and the bioassay for mycelial 
analysis. It appears that these three assay systems may be 
useful to study the kinetics of toxin production within the 
mycelium as well as its extra-cellular release.
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A method for quantitative determination of trichothecin in crude culture 
filtrates was presented. The method utilized an agar diffusion bioassay against 
Candida albicans, a colorimetric test involving a halochromatic reaction with 
sulfuric acid, and subsequent formation of blue color with methanol, and 
thin layer diromatography of tridiothecin and its dinitrophenylhydrazine deriv- 
ative. A positive result in all three systems confirmed the presence of tricho­
thecin. Quantitative results were generally in close agreement.
Trichothecin (T-cin) is a  member of a family 
of mycotozins known as the 12.13-epozytricho- 
tbecenes. Members of this family share the 
property of strongly inhibiting protein synthesis 
in eucaiyotic cells, although at least two differ­
ent mechanisms of inhibition exist within the 
group (3, 10). T-cin is one of the most potent 
antifungal members of the group and one of the 
least effective against mammalian cells (2).
Until recently, demonstration of the tricho- 
thecenes required relatively pure samples since 
these compounds are not fluorescent and do not 
lend themselves easily to the usual methods of 
assay. For these reasons, assay procedures ap­
plicable to crude samples are badly needed (2). 
Ueno et al, (12) described a procedure for 
screening cultures and foodstuffs for Fusarium 
trichothecenes based on both biological (animal 
toxicity and inhibition of reticulocyte protein 
synthesis) and chemical (thin-layer chromatog­
raphy) properties. No such procedure is cur­
rently available for T-cin.
Dcediobi et al. (6) have developed a gas 
chromatography system for the detection and 
quantitation of several trichothecenes including 
T-cin. Although their system has been used to 
detect T-2 toxin in crude grain extracts, its use 
with T-cin has so far been confined to mixtures 
pure crystalline samples.
Thin-layer chromatographic methods have 
been described for all of the trichothecenes (2, 
12). We have tried several of these with crude 
extracts of Trichothecium roseum cultures but 
were usable to achieve adequate separation.
The purpose of this communication is to 
describe procedures currently being used in our 
laboratory for the detection of T-cin in crude 
culture extracts.
MATERIALS AND METHODS
T-cin was prepared by cultivation of T. roseum 
(Pert.) Link ex S. F. (îray (NRRL 1665) by the 
method of Freeman and Morrison (5), except that 
Fembach flasks were used, each containing ml of 
medium. After 21 days of incubation, the  mycelium 
was removed by filtration, and the filtrate was ex­
tracted three times with carbon tetrachloride (200 
ml/liter of filtrate). The combined extracts were dried 
by filtration through anhydrous NsiSO. concentrated 
in vacuo, and diluted to a final volume of 10.0 ml 
in a volumetric flask. These crude extracts were 
used for qualitative and quantitative assays and for 
preparation of crystalline toxin.
Standard samples o: crystalline T-cin were pre­
pared from crude CCI. extracts by column chromatog­
raphy on A1,0| (II) with the benzene-ether stepwise 
elution method of Achilladelis and Hanson (1). 
Column fractions were screened by bioassay, and 
active fractions were pooled and concentrated in 
vacuo. T-cin was crystallized from CH.OH-HiO 
mixtures and recrystallized from petroleum ether. Its 
identity was confirmed by nuclear magnetic reso­
nance analysis.
Bioassay. Qualitative and semiquantitative assay 
was carried out by the agar diffusion method against 
Candida albicans strain Ml-023 obtained from the 
Center for Disease Control in Atlanta, Ga. Inoculum 
was prepared in a modified Wickerham medium 
(13) consisting of Wickerham's trace elements and 
salts (ammonium sulfate omitted), 1% glucose, 0.5% 
vitamin-free Casamino Acids (Difco), and 0.01% yeast 
extract. A 10-ml basal agar layer was covered by a 
6-ml seed agar la^ ^  containing 24-h cells at a density 
of 2 X 10* organisms/ml. Nutrient agar (Difco) was 
used in both layers. A standard volume (0.1 ml) of the 
extract or dilution to be tested was added to 
Schleicher and Schuell antibiotic disks (12.7 mm), 
and the disks were permitted to stand a minimum of 
30 min a t ambient room temperature to allow evapo­
ration of the solvent. The disks were applied to the 
plates 30 min after the seed agar layer was poured.
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and the plate* were incubated a t 37 C for 24 h.
Calaeiimetrir  aaaay. Colorimetric a*cay of these 
extracts was accomplished by a modification of the 
procedure developed by Poltorak (7). Concentrated 
H^SO. (1.5 ml) was added to 0.5 ml of extract (in CCI. 
or benzene) to be tested. The tube was then agitated 
immediately on a Vortex mixer and placed in a 
boUing-water bath for 4 min. The presence of T-cin or 
other o.)J-unsaturated ketones is indicated by the 
development of a red-brown color (71. After cooling for 
1 to 2 min. this mixture was added cautiously to 7.5 
ml of absolute methanol. Under these conditions. 
T-cin produces a blue color within a few minutes 
which is stable for several hours (7). The final 
solutions were read a t 600 nm in a Beckman DB-G 
spectrophotometer after a minimum of 30 min.
Thin-layer chromatography. Silica Gel (Brink­
man) a t a thickness of about 375 ^m was applied to 
plates (20 by 20 cm) with a Desaga spreader. Mnllinck- 
rodt Silicar 7G (250 «iml produced essentially similar 
results. The plates were activated at 110 C overnight 
and stored in a Lab Con Co vacuum desiccator 
(atmospheric pressure) prior to use. Separation of 
substances by chromatography can often be enhanced 
by repeated development in the same solvent system 
(11). The plates were spotted for either single or 
double development (12 cm) and were developed by 
the  following solvent systems: (i) benzene-ethyl ace­
tate  (95:5). double development; (ii) benzene-acetone 
(95:5). double development: and (iii) chlorofonn- 
ethyl acetate (9:1). single development.
After development, the plates were sprayed with a 
1:1 mixture of concentrated HtSO. and absolute 
methanol and developed at 110 C for 15 min. T-cin 
appeared as a brown nonfluorescent spot (long wave 
ultraviolet) which eventually began to fade and 
became surrounded by a white halo.
To enhance the value of thin-layer chromatography 
in identifying T-cin. 2.4-dinitrophenylhydrazine de­
rivatives were prepared from crude extracts, crystal­
line T-cin. and acetone. The 2.4-dinitrophenylhydra­
zine reagent was prepared by the method of Roberts et 
al. (9). The reagent (1 ml) was mixed with 0.5 ml of 
extract on a watch glass and stirred occasionally until 
2.4-dinitrophenylhydrazones were formed. These were 
collected by filtration through glass wool in a capillary 
pipette and washed repeatedly with ethanol. The 
product was then eluted into a test tube with about I 
ml of chloroform. Dinitrophenylhydrazine derivatives 
were used as a confirmatory test and were not used for 
quantitative purposes. The acetone-dinitrophenylhy- 
drazooe was used for relative Rr determinations (not 
shown).
Semiquantitative estimation of T-cin concentra­
tions in crude extracts was done by visual comparison 
with known concentrations of crystalline T-cin on the 
same plate.
To compare these procedures for the quantitative 
analysis of individual samples, a series of eight 
culture filtrates was prepared and analyzed as de­
scribed above. In each case, dilutions were prepared 
with CCI4 whenever required. Analysis of variance 
was done by standard methods for two factors and one 
observation per cell (4).
Several strains of T. roseum were used to compare 
these methods of analysis and to determine wrbether 
different strains might present unique problems in 
extraction or analysis. These were obtained from C. 
W. Hesseltine of the Northern Regional Research 
Laboratory (NRRL 1665 and 2307). from J. L. Richard 
of the National Animal Disease Laboratory. Ames, 
Iowa (MC-156 and MC-176). and from the A m ericu 
Type Culture Collection (ATCC 13411 and 13422). 
Two of the strains were isolated from natural sources 
in Oklahoma (FL-1 from soil in Norman and RH-1 
from a squash from Elk City). Each strain was 
cultured and extracted as described above.
RESULTS
Although the bioassay was intended initially 
only for qualitative purposes, it can be used 
semiquantitatively as well; a linear relationship 
holds between the log of concentration and the 
diameter of the zone of inhibition over the 
concentration range of 50 pg/ml to 2 mg/ml 
(Fig. 1). Since only O.I ml of extract is used per 
disk, a definite zone of inhibition is produced if 
about 2 to 5 Mg of T-cin is present on the disk.
The Poltorak colorimetric procedure yields a 
linear relationship between 0.2 to 3.0 mg/ml 
(Fig. 2). although certain unknown substances 
may cause interference in some cases. The 
presence of interfering a.d-unsaturated ketones 
is indicated by a pink or purple color resulting 
from residual red-colored products of the first 
reaction.
R, values for T-cin. T-cin-dinit rophenyIhy- 
drazone. and acetone-dinitrophenylhydrazone 
are presented in Table 1. The minimum amount 
of T-cin orT-cin-dinitrophenylhydrazone which 
could be easily detected was 6 to 10 ftgjspot. 
These solvent systems afford good separation of 
T-cin and an unknown contaminating sub-
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Fic. 1. Linear relationship between the diameter 
of the tone of M iibition of C. albicans and the log of 
the T-cin concentration (y •  14.0x 7.0; r .  0S9O.







F k . 2. Linear relationship between absorbance of 
reaction products and T-cin concentration ly  -  0.4x 
-  0.039. r  -  0S9I).






Benzene-etac* (95:51. 0.14 0.22 0.67
double development
Benzene acetone (95:5). 0.35 0.48 0.76
double development
Chloroform-etac (9:1). 0.44 0.58 0.74
single development
•DNP. Dinitrophenylhydraione.
*E uc. Ethyl acetate.
stance which overlapped T^cin in several other 
solvent systems previously reported (Fig. 31.
Table 2 presents the results of a quantitative 
comparison of a series of eight culture filtrates. 
Although agreement was not complete (e.g.. 
RH-1 and MC-156). the results of the three 
assay methods were in general agreement. Anal­
ysis of variance of these data (Table 3) shows 
that the different strains used were significantly 
different in their production of T-cin. but that 
there was no statistically significant difference 
in results obtained by the three assay methods.
DISCUSSION
The minimum detectable levels in the bioas­
say, Poltorak colorimetric reaction, and thin- 
layer chromatt%raphy are 50 rrg/ml. 200 rrg/ml, 
and about 6 pg. respectively. Under the condi­
tions employed, the bioassay is the most sensi­
tive of the three methods. Because of the 
limited loading capacity inherent in analytical 
thin-layer chromatography, working samples 
must contain about 0.5 to 1.0 mg/ml. Therefore
thin-layer chromatography is the least sensitive 
of the methods. A major disadvantage of the 
bioassay is its lack of specificity, since many 
naturally occurring substances inhibit C. 
albicans. Its convenience, simplicity, and econ­
omy make it a useful screening technique.
The specifîcity of the colorimetric test is 
currently not known. According to Poltorak (7). 
it is dependent upon a halochromatic reaction 
between concentrated H,SO« and the a.d- 
unsaturated keto group of T-cin. While we have 
not studied this point, we have tried quinhy- 
drone (a mixture of quinone and hydroquinone) 
with H1SO4 under the conditions of the Poltorak 
test. Only a faint yellow color developed at a 
concentration of 1 mg/ml. Therefore, the red- 
brown color resulting from halochromation of 
T-cin is not a general phenomenon of a,0- 
unsaturated ketoner.
It would be helpful to know the structural 
requirements for this reaction and the subse­
quent reaction, i.e.. the formation of the blue 
color with methanol. The Poltorak reaction is 
somewhat limited by its uncertain specificity 
and by the possibility of interference resulting 
from the occasional occurrence of turbid solu-




1665 16.2 14.2 13.3
2307 16.6 16.1 16.7
FL-1 5.5 5.8 5.0
RH-1 11.6 6.8 11.4
MC-156 0.3 1.5 0.3
MC-176 1.9 2.3 2.0
13411 1.3 1.5 1.2
13422 2.3 2.9 2.0
‘ Expressed as milligrams of T-cin per milliliter of 
extract.
•Average values: bioassay. 7.0; colorimetric. 6.4; 
and thin-layer chromatography (TLC), 6.5
T a b le  3. Analysis o f variance'
Source of variation DF* SS* MS*
Strain 7 822.09 117.44*
Method of assay 2 1.51 0.76'
Error 14 19.69 1.41
'  Analysis of data in Table 2.
* DF. Degrees of freedom.
'  SS. Sum of squares.
'  MS. mean square.
'  Significant at the 51  level of probability. 
'Insignificant.
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Fic. 3. Thin-laytr chromatographic separation of 
two cuUurt filtrate extracts in bemene-acetone (95.5. 
double development). Components were visualized by 
spraying with CH,OH-H^O, (1:1) followed by heat­
ing at HOC for IS min. Separatioru: (J) Extract no. I 
(strain MC-176), 2 #(. (2) extract no. 1 ,2  itl + 6 u g o f  
T-cin; (3) T-cin standard, 6 sg: (4) extract no. 2 (strain 
FL-l), I III; and (S) extract no. 2 ,1 ul ■¥ 6  ug of T-cin. 
Arrows: (a) origin, (b) T-cin, (c,d) major contamiruu- 
ing substances, and (e) solvent front.
tions and/or residual red-brown color from the 
K,SO« step. It is a useful screening tool, how­
ever. and offers greater specificity than the 
bioassay. Interfering substances can be removed 
by column chromatography if desired, but we 
believe that this is rarely necessary. The Pol­
torak colorimetric assay can be scaled down for 
qualitative purposes. This is helpful in testing 
column fractions or other samples when conser­
vation of material is desired. In this case, the 
volumes of samples. H,SO«. and methanol are 
reduced fivefold. Because the sample is in a 
volatile organic solvent which is readily driven 
off in the water bath, the sample volume may be 
increased five- to 10-fold for increased sensitiv­
ity. If desired, the final mixture can be poured 
onto a spot plate for e asier visual examination.
The uncertainty of R, values in identifying 
organic compounds is well known (II). but by 
the use of multiple solvent systems and chro­
matography of deri\‘ati\’es (i.e.. 2,4-dinitro- 
phenylhydrazone-T-cin) the problem of speci­
ficity can be minimized. Although the spray 
used resembles the Poltorak reaction system, T- 
cin does not form a blue spot on thin-layer 
diromatography plates. However, the spray is 
useful because it produces fluorescent spots 
writh certain other compounds on the plates, 
which aids in the interpretation of chromato­
grams. Also it allows dtaning of organic com­
pounds present and gives a recognizable reac­
tion with T-cin.
Richard et al. (8) previously tepmted that T. 
roseum NRRL 2307 does not produce T-cin. 
However, our results indicate yields comparable 
to those of NRRL 1665. Perhaps the subculttire 
used in their work had lost its ability to produce 
the compound. We were able to detect T-cin in 
all of the extracts reported herein, although the 
yields were often quite low. It is interesting tha t 
we have tried only two fresh isolates from 
Oklahoma, and that both produced the toxin 
under these conditions in yields comparable to 
those originally reported Iv  Freeman and Mor­
rison (5).
Although each of the assay procedures used 
has certain inherent disadvantages, their use in 
combination allows qualitative determination 
of T-cin without purification, and quantisation 
by these methods yields results which are gener­
ally in close agreement.
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